×
Displaying 1 - 10 of 72
First
«
1
2
3
4
5
»
Last
Personalised medicine in advanced breast cancer: AI-driven genomic test for CDK4/6 treatment response prediction
Personalised medicine in advanced breast cancer: AI-driven genomic test for CDK4/6 treatment response prediction
Speaker(s):
Alicja Woźna
,
MSc
,
Adam Mickiewicz University
Human Papilloma Virus Integration Strictly Correlates with Global Genome Instability in Head and Neck Cancer
Human Papilloma Virus Integration Strictly Correlates with Global Genome Instability in Head and Neck Cancer
Speaker(s):
David Goldrich
,
MD
,
Penn State Milton S. Hershey Medical Center
Cancer patient survival can be accurately parameterized, revealing time-dependent therapeutic effects and doubling the precision of small trials
Cancer patient survival can be accurately parameterized, revealing time-dependent therapeutic effects and doubling the precision of small trials
Speaker(s):
Deborah Plana
,
BS
,
Harvard Medical School
Detecting Bacterial-Human Lateral Gene Transfer in Chronic Lymphocytic Leukemia
Detecting Bacterial-Human Lateral Gene Transfer in Chronic Lymphocytic Leukemia
Speaker(s):
Ekaterina Akimova
,
MSc
,
Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR)
Synthetic lethality-mediated precision oncology via the tumor transcriptome
Synthetic lethality-mediated precision oncology via the tumor transcriptome
Speaker(s):
Joo S. Lee
,
PhD
,
National Cancer Institute
Ex vivo expansion and drug sensitivity profiling of circulating tumor cells in patients with soft tissue sarcoma
Ex vivo expansion and drug sensitivity profiling of circulating tumor cells in patients with soft tissue sarcoma
Speaker(s):
Long-Sheng Lu
,
MD, PhD
,
Taipei Medical University
An unveiled Cell-Death Mechanism Exclusive to Human Cancer Cells
An unveiled Cell-Death Mechanism Exclusive to Human Cancer Cells
Speaker(s):
Malka Armon
,
PhD
,
Tel-Aviv University
The development of a personalized CAM Avatar model to predict chemotherapeutic drug sensitivity/resistance of malignant glial tumors.
The development of a personalized CAM Avatar model to predict chemotherapeutic drug sensitivity/resistance of malignant glial tumors.
Speaker(s):
Martine Charbonneau
,
MSc
,
Sherbrooke University
Clinical Feasibility and Treatment Outcomes With Unselected Autologous Tumor Infiltrating Lymphocyte Therapy in Patients With Advanced Cutaneous Melanoma
Clinical Feasibility and Treatment Outcomes With Unselected Autologous Tumor Infiltrating Lymphocyte Therapy in Patients With Advanced Cutaneous Melanoma
Speaker(s):
Robert Hawkins
,
PhD
,
Instil Bio, Inc.
Unraveling the Molecular Determinants of Keloid Formation and Variable Effects of Steroid Treatment using Patient Derived Keloid Fibroblasts
Unraveling the Molecular Determinants of Keloid Formation and Variable Effects of Steroid Treatment using Patient Derived Keloid Fibroblasts
Speaker(s):
Yuna Son
,
MS
,
Florida State University
Displaying 1 - 10 of 72
First
«
1
2
3
4
5
»
Last
×
Evaluation